A jump in prescription drug sales and a sharply reduced tax bill boosted Johnson & Johnson's third-quarter sales and profit, which beat Wall Street expectations. The world's biggest maker of health care products on Tuesday also slightly raised its profit forecast for the year. The New Brunswick, N.J., maker of baby products, biotech drugs and medical devices reported net income of $3.93 billion, or $1.44 per share.Read more on NewsOK.com